Variable | All patients (N = 146) | Favorable (N = 30) | Unfavorable (N = 116) | p value |
---|---|---|---|---|
Organ support | ||||
Duration of mechanical ventilation, days | 15 [7–36] | 33 [19–45] | 14 [5–28] | < 0.001 |
Vasopressors | 109 (82) | 25 (83) | 84 (72) | 0.06 |
Duration of vasopressor treatment, days | 6 [3–11] | 7 [4–16] | 6 [2–11] | 0.09 |
Neuromuscular blocking agent | 131 (90) | 26 (87) | 105 (91) | 0.54 |
Prone positioning | 111 (76) | 24 (80) | 87 (75) | 0.57 |
Renal replacement therapy | 66 (45) | 12 (40) | 54 (47) | 0.52 |
Duration of renal replacement therapy, days | 5 [2–11] | 6 [3–21] | 5 [2–10] | 0.29 |
ECMO | 20 (14) | 4 (13) | 16 (14) | 0.95 |
Targeted temperature management | 7 (5) | 3 (10) | 4 (3) | 0.13 |
Outcome at ICU discharge | ||||
Death | 102 (70) | – | 102 (88) | – |
New in-ICU CA occurrence | 31 (21) | – | 31 (27) | – |
Unsuccessful CPR attempt | 29 (20) | – | 29 (25) | – |
From WLST | 21 (14)a | – | 21 (18) | – |
From multi-organ failure | 18 (12) | – | 18 (16) | – |
From refractory ARDS | 3 (2) | – | 3 (3) | – |
Duration of ICU hospitalization, days | 20 [8–42] | 45 [28–71] | 16 [7–33] | < 0.001 |
Outcome at day 90 after in-ICU CA | ||||
Died | 106 (73) | – | 106 (91) | - |
Remained hospitalized | 2 (1) | 0 (0) | 2 (2) | 0.47 |
Duration of hospitalization, days | 26 [10–54] | 59 [46–94] | 17 [8–38] | < 0.001 |
Modified Rankin scale | ||||
0 | 6 (4) | 6 (20) | – | – |
1 | 9 (6) | 9 (30) | – | – |
2 | 10 (7) | 10 (33) | – | – |
3 | 5 (3) | 5 (16) | – | – |
4 | 6 (4) | – | 6 (7) | – |
5 | 4 (3) | – | 4 (3) | – |